At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 51 enrolled
Drug / intervention
Naltrexone +1 moredrug
Likely dose
Naltrexone 50mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-blind, Placebo-controlled Study of Naltrexone in Trichotillomania
In Brief
A Phase 2 clinical trial evaluating Naltrexone and Placebo for Trichotillomania. Completed, enrolled 51 participants across 1 site.
Detailed Summary
This is an 8-week, double-blind study of Natrexone in the treatment of trichotillomania
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTrichotillomania
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2008
First PostedOct 2008
Primary CompletionNov 2012
Study CompletionDec 2012
TodayJul 2026
First PostedOct 20, 2008
Enrollment StartAug 1, 2008
Primary CompletionNov 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 17.7 years ago
Interventions
Naltrexonedrug
pill, by mouth, 50mg-150mg/day for the duration of the study
Placebodrug
pill, by mouth, daily